Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

FDA Makes Public Some Drug Data

by Britt E. Erickson
June 9, 2014 | A version of this story appeared in Volume 92, Issue 23

FDA has made available millions of reports on medication errors and adverse events associated with prescription drugs from 2004 to 2013 as part of a new Web-based platform called openFDA. Previously, these data were available to researchers only through Freedom of Information Act requests and difficult-to-use reports. The data do not contain personal information or anything that could potentially be used to identify individuals, FDA says. The agency plans to expand the program in the future to include data on product recalls and product labeling. The openFDA platform uses a search tool that ranks results much like Google does. Users can choose which data they want to search and how the results will be displayed. “OpenFDA offers a scalable platform that can be easily searched and queried across many distinct data sets and can be easily redeployed or altered to fit a variety of purposes,” says Taha A. Kass-Hout, FDA’s chief health informatics officer.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.